158 related articles for article (PubMed ID: 27811996)
1. A simplified Bcl-2 network model reveals quantitative determinants of cell-to-cell variation in sensitivity to anti-mitotic chemotherapeutics.
Kueh HY; Zhu Y; Shi J
Sci Rep; 2016 Nov; 6():36585. PubMed ID: 27811996
[TBL] [Abstract][Full Text] [Related]
2. Mitosis and apoptosis: how is the balance set?
Topham CH; Taylor SS
Curr Opin Cell Biol; 2013 Dec; 25(6):780-5. PubMed ID: 23890995
[TBL] [Abstract][Full Text] [Related]
3. Critical role of anti-apoptotic Bcl-2 protein phosphorylation in mitotic death.
Eichhorn JM; Sakurikar N; Alford SE; Chu R; Chambers TC
Cell Death Dis; 2013 Oct; 4(10):e834. PubMed ID: 24091677
[TBL] [Abstract][Full Text] [Related]
4. Navitoclax (ABT-263) accelerates apoptosis during drug-induced mitotic arrest by antagonizing Bcl-xL.
Shi J; Zhou Y; Huang HC; Mitchison TJ
Cancer Res; 2011 Jul; 71(13):4518-26. PubMed ID: 21546570
[TBL] [Abstract][Full Text] [Related]
5. CDK1 switches mitotic arrest to apoptosis by phosphorylating Bcl-2/Bax family proteins during treatment with microtubule interfering agents.
Zhou L; Cai X; Han X; Xu N; Chang DC
Cell Biol Int; 2014 Jun; 38(6):737-46. PubMed ID: 24677263
[TBL] [Abstract][Full Text] [Related]
6. Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.
Inoue-Yamauchi A; Jeng PS; Kim K; Chen HC; Han S; Ganesan YT; Ishizawa K; Jebiwott S; Dong Y; Pietanza MC; Hellmann MD; Kris MG; Hsieh JJ; Cheng EH
Nat Commun; 2017 Jul; 8():16078. PubMed ID: 28714472
[TBL] [Abstract][Full Text] [Related]
7. BCL-W is a regulator of microtubule inhibitor-induced mitotic cell death.
Huang S; Tang R; Poon RY
Oncotarget; 2016 Jun; 7(25):38718-38730. PubMed ID: 27231850
[TBL] [Abstract][Full Text] [Related]
8. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
[TBL] [Abstract][Full Text] [Related]
9. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L
Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663
[TBL] [Abstract][Full Text] [Related]
10. Cell fate after mitotic arrest in different tumor cells is determined by the balance between slippage and apoptotic threshold.
Galán-Malo P; Vela L; Gonzalo O; Calvo-Sanjuán R; Gracia-Fleta L; Naval J; Marzo I
Toxicol Appl Pharmacol; 2012 Feb; 258(3):384-93. PubMed ID: 22178383
[TBL] [Abstract][Full Text] [Related]
11. Chromosome alignment-maintaining phosphoprotein CHAMP1 plays a role in cell survival through regulating Mcl-1 expression.
Hino M; Iemura K; Ikeda M; Itoh G; Tanaka K
Cancer Sci; 2021 Sep; 112(9):3711-3721. PubMed ID: 34107118
[TBL] [Abstract][Full Text] [Related]
12. Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis.
Hlavac M; Dwucet A; Kast RE; Engelke J; Westhoff MA; Siegelin MD; Debatin KM; Wirtz CR; Halatsch ME; Karpel-Massler G
Cell Oncol (Dordr); 2019 Jun; 42(3):287-301. PubMed ID: 30859392
[TBL] [Abstract][Full Text] [Related]
13. Cellular responses to a prolonged delay in mitosis are determined by a DNA damage response controlled by Bcl-2 family proteins.
Colin DJ; Hain KO; Allan LA; Clarke PR
Open Biol; 2015 Mar; 5(3):140156. PubMed ID: 25761368
[TBL] [Abstract][Full Text] [Related]
14. The identification of BCL-XL and MCL-1 as key anti-apoptotic proteins in medulloblastoma that mediate distinct roles in chemotherapy resistance.
Fitzgerald MC; O'Halloran PJ; Kerrane SA; Ní Chonghaile T; Connolly NMC; Murphy BM
Cell Death Dis; 2023 Oct; 14(10):705. PubMed ID: 37898609
[TBL] [Abstract][Full Text] [Related]
15. Role of cyclin B1/Cdc2 in mediating Bcl-XL phosphorylation and apoptotic cell death following nocodazole-induced mitotic arrest.
Choi HJ; Zhu BT
Mol Carcinog; 2014 Feb; 53(2):125-37. PubMed ID: 22949227
[TBL] [Abstract][Full Text] [Related]
16. BCL-XL regulates the timing of mitotic apoptosis independently of BCL2 and MCL1 compensation.
Yu CY; Yeung TK; Fu WK; Poon RYC
Cell Death Dis; 2024 Jan; 15(1):2. PubMed ID: 38172496
[TBL] [Abstract][Full Text] [Related]
17. Cdk1/cyclin B plays a key role in mitotic arrest-induced apoptosis by phosphorylation of Mcl-1, promoting its degradation and freeing Bak from sequestration.
Chu R; Terrano DT; Chambers TC
Biochem Pharmacol; 2012 Jan; 83(2):199-206. PubMed ID: 22024133
[TBL] [Abstract][Full Text] [Related]
18. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2 proteins for insights into its interaction mechanism for anti-cancer activity.
Anantram A; Kundaikar H; Degani M; Prabhu A
J Biomol Struct Dyn; 2019 Aug; 37(12):3109-3121. PubMed ID: 30526410
[TBL] [Abstract][Full Text] [Related]
20. The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1.
Chang LC; Yu YL; Liu CY; Cheng YY; Chou RH; Hsieh MT; Lin HY; Hung HY; Huang LJ; Wu YC; Kuo SC
Cancer Chemother Pharmacol; 2015 Jun; 75(6):1303-15. PubMed ID: 25947085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
